Chargement en cours...
Therapeutic Advances in Cutaneous T-Cell Lymphoma
A variety of novel therapeutic modalities have recently become available for patients with cutaneous T cell lymphoma (CTCL). In particular, with recent FDA approvals of the three new agents vorinostat (Zolinza(®)), romidepsin (Istodax(®)), and pralatrexate (Folotyn(®)) CTCL treatment has been transf...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2011
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3954531/ https://ncbi.nlm.nih.gov/pubmed/21591544 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|